The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy in South Africa: a model-based analysis.

Andrews, JR; Lawn, SD; Rusu, C; Wood, R; Noubary, F; Bender, MA; Horsburgh, CR; Losina, E; Freedberg, KA; Walensky, RP; (2012) The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy in South Africa: a model-based analysis. AIDS (London, England). ISSN 0269-9370 DOI: https://doi.org/10.1097/QAD.0b013e3283522d47

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1097/QAD.0b013e3283522d47

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar